Loading clinical trials...
Loading clinical trials...
This trial is conducted in the United States of America (USA). The aim of this trial is to evaluate the safety profiles of Norditropin® (lyophilized somatropin) and Norditropin® cartridges (liquid som...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novo Nordisk A/S
NCT06109935 · Growth Hormone Deficiency in Children
NCT02616562 · Growth Hormone Disorder, Growth Hormone Deficiency in Children
NCT04970654 · Growth Hormone Deficiency in Children
NCT01706783 · Growth Hormone Disorder, Adult Growth Hormone Deficiency
NCT01514500 · Growth Hormone Disorder, Adult Growth Hormone Deficiency, and more
Novo Nordisk Investigational Site
Los Angeles, California
Novo Nordisk Investigational Site
Los Angeles, California
Novo Nordisk Investigational Site
Wilmington, Delaware
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions